Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.

Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.

Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed oligometastasis(es) characterized by limited progression has been proposed. Oligometastases are amenable to treatment by surgical resection or r...

Full description

Bibliographic Details
Main Authors: Yves A Lussier, Nikolai N Khodarev, Kelly Regan, Kimberly Corbin, Haiquan Li, Sabha Ganai, Sajid A Khan, Jennifer L Gnerlich, Thomas E Darga, Hanli Fan, Oleksiy Karpenko, Philip B Paty, Mitchell C Posner, Steven J Chmura, Samuel Hellman, Mark K Ferguson, Ralph R Weichselbaum
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3518475?pdf=render
Description
Summary:Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed oligometastasis(es) characterized by limited progression has been proposed. Oligometastases are amenable to treatment by surgical resection or radiotherapy.We analyzed microRNA expression patterns from lung metastasis samples of patients with ≤ 5 initial metastases resected with curative intent.Patients were stratified into subgroups based on their rate of metastatic progression. We prioritized microRNAs between patients with the highest and lowest rates of recurrence. We designated these as high rate of progression (HRP) and low rate of progression (LRP); the latter group included patients with no recurrences. The prioritized microRNAs distinguished HRP from LRP and were associated with rate of metastatic progression and survival in an independent validation dataset.Oligo- and poly- metastasis are distinct entities at the clinical and molecular level.
ISSN:1932-6203

Similar Items